Arbutus Biopharma (ABUS) Dividends Paid - Preferred (2018 - 2021)
Arbutus Biopharma's (ABUS) quarterly Dividends Paid - Preferred came in at $574000.0 in Q4 2021, down 81.62% year-on-year from $3.1 million in Q4 2020, and down 88.72% quarter-over-quarter from $5.1 million in Q3 2021.
Arbutus Biopharma (ABUS) Dividends Paid - Preferred (2018 - 2021) Analysis & Trends
Arbutus Biopharma has disclosed Dividends Paid - Preferred across 4 years of filings, most recently posting $574000.0 for Q4 2021.
- Dividends Paid - Preferred for Q4 2021 came in at $574000.0, down 81.62% year-over-year; the trailing twelve-month figure through Sep 2022 was $574000.0 (down 96.09% YoY), and the FY2021 annual result was $12.1 million, changed 0.13% from the prior year.
- Dividends Paid - Preferred came in at $574000.0 for Q4 2021 at Arbutus Biopharma, down from $5.1 million in the prior quarter.
- In the past five years, Dividends Paid - Preferred ranged from a high of $5.7 million in Q4 2019 to a low of $574000.0 in Q4 2021.
- The 4-year median for Dividends Paid - Preferred is $2.9 million (2019), against an average of $3.0 million.
- Across the five-year window, Dividends Paid - Preferred jumped 114.28% in 2019 and tumbled 81.62% in 2021, its largest moves.
- Arbutus Biopharma's Dividends Paid - Preferred stood at $2.6 million in 2018, then jumped by 114.28% to $5.7 million in 2019, then slumped by 44.94% to $3.1 million in 2020, then plunged by 81.62% to $574000.0 in 2021.
- The last three Dividends Paid - Preferred figures came in at $574000.0 (Q4 2021), $5.1 million (Q3 2021), and $3.3 million (Q2 2021), per Business Quant data.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Dividends Paid - Preferred (Qtr) |
|---|---|---|---|---|---|
| 1 | Alterity Therapeutics | 925,601.88 Bn | 925,601.85 Bn | - | - |
| 2 | Belite Bio | 58,560.00 Bn | 58,560.00 Bn | - | - |
| 3 | Quantum Biopharma | 17,284.41 Bn | 17,284.40 Bn | - | - |
| 4 | Legend Biotech | 2,809.00 Bn | 2,808.71 Bn | 242.10 Mn | - |
| 5 | Evaxion A | 1,334.43 Bn | 1,334.42 Bn | - | - |
| 6 | Akari Therapeutics | 1,312.27 Bn | 1,312.26 Bn | - | - |
| 7 | Psyence Biomedical | 212.16 Bn | 212.16 Bn | - | - |
| 8 | Vertex Pharmaceuticals | 114.83 Bn | 107.58 Bn | 2.59 Bn | - |
| 9 | Abivax | 91.96 Bn | 91.96 Bn | - | - |
| 10 | Arbutus Biopharma | 882.62 Mn | 882.62 Mn | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2021 | 574,000.00 |
| Dec 31, 2021 | 574,000.00 |
| Sep 30, 2021 | 5.09 Mn |
| Sep 30, 2021 | 5.09 Mn |
| Jun 30, 2021 | 3.27 Mn |
| Jun 30, 2021 | 3.27 Mn |
| Mar 31, 2021 | 3.21 Mn |
| Mar 31, 2021 | 3.21 Mn |
| Dec 31, 2020 | 3.12 Mn |
| Dec 31, 2020 | 3.12 Mn |
| Sep 30, 2020 | 3.03 Mn |
| Sep 30, 2020 | 3.03 Mn |
| Jun 30, 2020 | 3.00 Mn |
| Jun 30, 2020 | 3.00 Mn |
| Mar 31, 2020 | 2.98 Mn |
| Mar 31, 2020 | 2.98 Mn |
| Dec 31, 2019 | 5.67 Mn |
| Dec 31, 2019 | 5.67 Mn |
| Sep 30, 2019 | 2.79 Mn |
| Sep 30, 2019 | 2.79 Mn |